BVS vs CCI · rev $573.3M vs P/E 40, rev $6.57B
Bioventus Inc (BVS) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
BVS currently screens at market cap $495.1M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the BVS and CCI stock pages for the full models.
Not investment advice.